2.5. Synthesis of Pluronic® F-127 Micelles

KE Kadie Edwards
SY Seydou Yao
SP Simone Pisano
VF Veronica Feltracco
KB Katja Brusehafer
SS Sumanta Samanta
OO Oommen P. Oommen
SG S. Andrea Gazze
RP Roberta Paravati
HM Holly Maddison
CL Chao Li
DG Deyarina Gonzalez
RC R. Steven Conlan
LF Lewis Francis
request Request a Protocol
ask Ask a question
Favorite

Pluronic® F-127 (NP) and thiol-terminated Pluronic® F-127 (NP-S-S) micelles were fabricated using thin-film hydration method described by Caldwell et al. [63]. The polymer constituent and 10 wt/wt.% SAHA (Cayman Chemical Company, 10009929, Ann Arbor, MI, USA)/propidium iodide (Sigma-Aldrich, P4170-10MG) were dissolved in acetonitrile (ACN). The acetonitrile was removed by rotary evaporation at 65 °C and under 226 mbar for 1 h, and the flask placed into a desiccator under vacuum overnight, to ensure the film was void of all moisture and residual copolymer matrix acetonitrile removed. Prior to hydration, samples were heated to 65 °C in a water bath under mild rotation for 1 h until the sample resembled a viscous thin film coating the flask. NPs were hydrated in deionized water and returned to heated rotation for 30 min to ensure maximum micelle formation and drug loading. HA-thiol was added in excess (2:1) to NP-S-S and mixed using a magnetic stirrer at 700 rpm for 1 h to form NP-HA; prior to use HA-thiol was sterilized under UV for 1 h. An 0.22 or 0.45 μm filter (Millipore, Burlington, MA, USA) was applied to SAHA-NP and SAHA-NP-HA to remove non-encapsulated drugs agglomeration.

Synthesis of thiolated Pluronic® F-127 (NP-S-S-Py).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A